Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

DrugBank

Drug (Description in trials)

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

Ipratropium
(Ipratropium Bromide and Salbutamol Sulphate Inhalation Solution)

[1] Ipratropium

-

-

-

[2] 6, 86 💬

2

Levosalbutamol
(R-salbutamol)

[2] R-salbutamol; Salbutamol

[1] Levosalbutamol 💬

[1] ADRB2 💬

[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[1] 49 💬

3

[3] Albuterol; Salbutamol; Ventolin

[1] Albuterol (Salbutamol) 💬

[1] ADRB2 💬

[9] Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[12] 3, 11, 12, 13, 49, 85, 86, 89, 111, 113, 256, 299 💬

Disease ID	Name
3	Spinal muscular atrophy
11	Myasthenia gravis
12	Congenital myasthenic syndrome
13	Multiple sclerosis/Neuromyelitis optica
49	Systemic lupus erythematosus
85	Idiopathic interstitial pneumonia
86	Pulmonary arterial hypertension
89	Lymphangioleiomyomatosis
111	Congenital myopathy
113	Muscular dystrophy
256	Muscle glycogenosis
299	Cystic fibrosis